Frequency of patients having low and high Cdh23 expression for different stages of cancer (in percentage) in LC and esophageal cancer tissue array (TMA) and TCGA patient groups (LUAD, LUSC, ESCC). This evidence concerns the gene CDH23 and esophageal cancer.